Science and innovation are the lifeblood of our company. But we’re doing more than developing medicines that perform well in the lab—we’re elevating the current standard of care to bring greater benefits to our patients.
Published 1,130 papers
AbbVie scientists in the medical research community published 1,130
papers in 2018 – allowing others to build on scientific knowledge
Bringing better solutions to patients
By investing in groundbreaking technologies and platforms, our goal is to drive innovation within our pipeline and deliver better solutions to patients.
products with potential for new drug or indication approvals by the end of 2020
programs in Phase 3/Registrational Phase
R&D employees working globally to make a difference
A portfolio of medicines
We aim to develop innovative therapies for health conditions where there is significant need. Our medicines are approved in individual countries for different uses around the globe.
Make new medicines possible
Whether you or a relative are interested in participating in a trial, our Clinical Trials and Me website can help address your questions. It offers information about clinical trials and lists our current clinical trials. You’ll also learn how to prepare for one and what to expect during and after a clinical trial.